PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY

被引：0
|
作者：
Kockaya, G. [1 ]
Ergin, Oguzhan G. [2 ]
Kurnaz, M. [3 ]
Okcun, S. [3 ]
Talay, D. [4 ]
Gedik, Sar C. [4 ]
Saylan, M. [4 ]
机构：
[1] ECONiX, Ankara, Turkey
[2] 19 Mayis Univ, Samsun, Turkey
[3] ECONiX, Istanbul, Turkey
[4] Hlth Econ & Policy Assoc, Ankara, Turkey
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO75
引用
下载
收藏
页码：S854 / S855
页数：2
相关论文
共 50 条
  • [41] Access to medicines
    Miljkovic, Nenad
    Makridaki, Despina
    Kohl, Stephanie
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (05) : 257 - 260
  • [42] Access to Medicines
    Pogge, Thomas
    PUBLIC HEALTH ETHICS, 2008, 1 (02) : 73 - 82
  • [43] RATES OF PATIENT-REPORTED OUTCOME CLAIMS FOR ORPHAN DRUGS APPROVED BY THE EUROPEAN MEDICINES AGENCY
    Jaroslawski, S.
    Toumi, M.
    Auquier, P.
    Dussart, C.
    VALUE IN HEALTH, 2018, 21 : S109 - S109
  • [44] THE ORPHAN PATIENT
    SHELLEY, WB
    SHELLEY, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (10): : 646 - 646
  • [45] Access to Medicines, Access to Markets
    Sismondo, Sergio
    FRONTIERS IN SOCIOLOGY, 2020, 5
  • [46] Public spending on orphan medicines: a review of the literature
    Gombocz, Margit
    Vogler, Sabine
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [47] Public spending on orphan medicines: a review of the literature
    Margit Gombocz
    Sabine Vogler
    Journal of Pharmaceutical Policy and Practice, 13
  • [48] AN ANALYSIS OF ORPHAN MEDICINES EXPENDITURE IN IRAN, 2018
    Hajimiri, S. H.
    Nazemi, N.
    Kebriaeezadeh, A.
    VALUE IN HEALTH, 2019, 22 : S857 - S857
  • [49] Precision Medicines' Impact on Orphan Drug Designation
    Mueller, Christine M.
    Rao, Gayatri R.
    Needleman, Katherine I. Miller
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, : 633 - 640
  • [50] Patient access to medicines for rare diseases in Slovenia and other European countries
    Deticek, Andreja
    Locatelli, Igor
    Kos, Mitja
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 220 - 221
12345